Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Carroll

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 17, 2015
Working to Eliminate Cancer Health Disparities from Tobacco: A Review of the National Cancer Institute's Community Networks ProgramElisa K Tong, Pebbles Fagan, Leslie Cooper, et al.
JNCI Cancer Spectrum|July 31, 2019
Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic LeukemiaStefania Galimberti, Meenakshi Devidas, Ausiliatrice Lucenti, et al.
Neurology|July 18, 2020
Serum neurofilament light as a biomarker in progressive multiple sclerosisRaju Kapoor, Kathryn E Smith, Mark Allegretta, et al.
Frontiers in Cardiovascular Medicine|September 19, 2022
Development and validation of a machine learned algorithm to IDENTIFY functionally significant coronary artery diseaseThomas Stuckey, Frederick Meine, Thomas McMinn, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 20, 2006
A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the ratPrisca Honore, Diana Donnelly-Roberts, Marian T Namovic, et al.
Head and Neck Pathology|December 20, 2012
Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinomaYufeng Li, Shuting Bai, William Carroll, et al.
Head and Neck Pathology|February 28, 2023
WPOI-5: Accurately Identified at Intraoperative Consultation and Predictive of Occult Cervical MetastasesJohn E Beute, Lily A Greenberg, Lauren E Wein, et al.
Neurology|June 21, 2015
International consensus diagnostic criteria for neuromyelitis optica spectrum disordersDean M Wingerchuk, Brenda Banwell, Jeffrey L Bennett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2024
Interim Phase II Results Using Panitumumab-IRDye800CW during Transoral Robotic Surgery in Patients with Oropharyngeal CancerLogan D Stone, Benjamin B Kasten, Shilpa Rao, et al.
Blood Advances|January 26, 2021
Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemiaAnjali S Advani, Eric Larsen, Kristina Laumann, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 17, 2015
Working to Eliminate Cancer Health Disparities from Tobacco: A Review of the National Cancer Institute's Community Networks ProgramElisa K Tong, Pebbles Fagan, Leslie Cooper, et al.
JNCI Cancer Spectrum|July 31, 2019
Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic LeukemiaStefania Galimberti, Meenakshi Devidas, Ausiliatrice Lucenti, et al.
Neurology|July 18, 2020
Serum neurofilament light as a biomarker in progressive multiple sclerosisRaju Kapoor, Kathryn E Smith, Mark Allegretta, et al.
Frontiers in Cardiovascular Medicine|September 19, 2022
Development and validation of a machine learned algorithm to IDENTIFY functionally significant coronary artery diseaseThomas Stuckey, Frederick Meine, Thomas McMinn, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 20, 2006
A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the ratPrisca Honore, Diana Donnelly-Roberts, Marian T Namovic, et al.
Head and Neck Pathology|December 20, 2012
Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinomaYufeng Li, Shuting Bai, William Carroll, et al.
Head and Neck Pathology|February 28, 2023
WPOI-5: Accurately Identified at Intraoperative Consultation and Predictive of Occult Cervical MetastasesJohn E Beute, Lily A Greenberg, Lauren E Wein, et al.
Neurology|June 21, 2015
International consensus diagnostic criteria for neuromyelitis optica spectrum disordersDean M Wingerchuk, Brenda Banwell, Jeffrey L Bennett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2024
Interim Phase II Results Using Panitumumab-IRDye800CW during Transoral Robotic Surgery in Patients with Oropharyngeal CancerLogan D Stone, Benjamin B Kasten, Shilpa Rao, et al.
Blood Advances|January 26, 2021
Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemiaAnjali S Advani, Eric Larsen, Kristina Laumann, et al.
Pageof 9